The Patent Finder

Temple University

Also on record
Records under this name other than the patents Temple University holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Temple University

PatentTitleStatus Expires Confidence
US 9,855,225Cannabinoid Receptor Treatments
Lapsed on the fee record
Ended Jan 2, 2026 · High confidence
Lapsed on the fee recordEnded Jan 2, 2026High confidence
US 9,163,088Novel Tumor Antigens Elicit Anti-Tumor Humoral Immune Reactions in a Subset of Patients with Polycythemia Vera
Lapsed on the fee record
Ended Oct 20, 2023 · High confidence
Lapsed on the fee recordEnded Oct 20, 2023High confidence
US 6,905,585Automated system for high-throughput electrophoretic separations
Term ended
Term ended Sep 10, 2023 · From the USPTO record
Term endedTerm ended Sep 10, 2023From the USPTO record
US 7,153,541Method for Inhibiting Oxidation of Metal Sulfide-Containing Material
Formerly held
Term ended
Term ended Aug 2, 2023 · High confidence
Term endedTerm ended Aug 2, 2023High confidence
US 7,981,674Osteoactivin Protein and Nucleic Acids Encoding the Same, Compositions and Methods of Stimulating Bone Differentiation
Lapsed on the fee record
Ended Jul 19, 2023 · High confidence
Lapsed on the fee recordEnded Jul 19, 2023High confidence
US 7,038,010Agents and Methods for Promoting Bone Growth
Term ended
Term ended Jun 15, 2022 · High confidence
Term endedTerm ended Jun 15, 2022High confidence
US 7,226,904Agents and Methods for Promoting Bone Growth
Term ended
Term ended Dec 13, 2021 · High confidence
Term endedTerm ended Dec 13, 2021High confidence
US 9,763,894Inflammation Therapy
Lapsed on the fee record
Ended Sep 19, 2021 · High confidence
Lapsed on the fee recordEnded Sep 19, 2021High confidence
US 6,812,002Osteoactivin Protein and Nucleic Acids Encoding the Same, Compositions and Methods of Stimulating Bone Differentiation
Term ended
Term ended Aug 30, 2021 · High confidence
Term endedTerm ended Aug 30, 2021High confidence
US 8,333,972Unconventional Antigen Translated by a Novel Internal Ribosome Entry Site Elicits Antitumor Humoral Immune Reactions
Lapsed on the fee record
Ended Dec 18, 2020 · High confidence
Lapsed on the fee recordEnded Dec 18, 2020High confidence
10 of 66 patents shown.
Pro members see all 66.
Pro members: see all 66 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited